EXPLORE!

US FDA removes boxed warning on LABA+ ICS combination for asthma and COPD

  1059 Views

#Allergy and Immunology  #Pulmonary Medicine 

eMediNexus    22 December 2017

In an updated drug safety communication released on December 20, 2017, the US FDA has removed the Boxed Warning about asthma-related death from the drug labels of medicines that contain long-acting beta agonists (LABAs) in combination with inhaled corticosteroids (ICS).

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.